Dr Robb Nels Larsen, MD - Medicare Orthopaedic Surgery in Springfield, OR

Dr Robb Nels Larsen, MD is a medicare enrolled "Orthopaedic Surgery" physician in Springfield, Oregon. His current practice location is 1435 G St, Springfield, Oregon. You can reach out to his office (for appointments etc.) via phone at (541) 242-4812.

Dr Robb Nels Larsen is licensed to practice in Oregon (license number MD26431) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1396738274.

Contact Information

Dr Robb Nels Larsen, MD
1435 G St,
Springfield, OR 97477-4113
(541) 242-4812
(541) 242-4813



Physician's Profile

Full NameDr Robb Nels Larsen
GenderMale
SpecialityOrthopaedic Surgery
Location1435 G St, Springfield, Oregon
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1396738274
  • Provider Enumeration Date: 08/26/2005
  • Last Update Date: 09/16/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 5294738142
  • Enrollment ID: I20060814000370

Medical Identifiers

Medical identifiers for Dr Robb Nels Larsen such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1396738274NPI-NPPES
028273MedicaidOR

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207X00000XOrthopaedic Surgery MD26431 (Oregon)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Robb Nels Larsen allows following entities to bill medicare on his behalf.
Entity NameSamaritan North Lincoln Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1306897491
PECOS PAC ID: 7911816301
Enrollment ID: O20040120000329

News Archive

Study: Majority of overweight or obese patients happy with abdominoplasty

Tummy tuck surgery (abdominoplasty) yields high patient satisfaction and improved quality of life in patients who are overweight or obese – despite a substantial risk of complications, reports a study in the October issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons.

Proposed FY13 State, Foreign Operations appropriations bill has 'mixed results' for USAID's global health programs

"On Thursday, the House Appropriations Committee will vote on a State and Foreign Operations (SFOPS) appropriations bill for fiscal year (FY) 2013, which will include funding levels for global health and other programs at the State Department and U.S. Agency for International Development (USAID)," Ashley Bennett, senior policy associate at the Global Health Technologies Coalition (GHTC) writes in the coalition's "Breakthroughs" blog.

Study refutes perinatal programming theory about adipose tissue growth

Is obesity in infants "programmed" in the womb? Previously, researchers assumed that consumption of "bad" fats during pregnancy contribute to excessive infant adipose tissue growth and that "good" omega-3 fatty acids prevent expansive adipose tissue development. A study run by the Technische Universit-t M-nchen showed no evidence to support this "perinatal programming" theory.

Phase 2b clinical study initiated to evaluate GI safety of LT-NS001

Logical Therapeutics, Inc., a Waltham, Mass.-based biotechnology company announced today the initiation of a Phase 2b clinical study to evaluate the gastrointestinal safety of its investigational drug LT-NS001 (naproxen etemesil). The study will compare the cumulative rate of gastric ulcers vs. Naprosyn after 12 weeks of treatment.

Read more Medical News

› Verified 4 days ago

Entity NameSilverton Health
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1669424354
PECOS PAC ID: 8921901877
Enrollment ID: O20040129000172

News Archive

Study: Majority of overweight or obese patients happy with abdominoplasty

Tummy tuck surgery (abdominoplasty) yields high patient satisfaction and improved quality of life in patients who are overweight or obese – despite a substantial risk of complications, reports a study in the October issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons.

Proposed FY13 State, Foreign Operations appropriations bill has 'mixed results' for USAID's global health programs

"On Thursday, the House Appropriations Committee will vote on a State and Foreign Operations (SFOPS) appropriations bill for fiscal year (FY) 2013, which will include funding levels for global health and other programs at the State Department and U.S. Agency for International Development (USAID)," Ashley Bennett, senior policy associate at the Global Health Technologies Coalition (GHTC) writes in the coalition's "Breakthroughs" blog.

Study refutes perinatal programming theory about adipose tissue growth

Is obesity in infants "programmed" in the womb? Previously, researchers assumed that consumption of "bad" fats during pregnancy contribute to excessive infant adipose tissue growth and that "good" omega-3 fatty acids prevent expansive adipose tissue development. A study run by the Technische Universit-t M-nchen showed no evidence to support this "perinatal programming" theory.

Phase 2b clinical study initiated to evaluate GI safety of LT-NS001

Logical Therapeutics, Inc., a Waltham, Mass.-based biotechnology company announced today the initiation of a Phase 2b clinical study to evaluate the gastrointestinal safety of its investigational drug LT-NS001 (naproxen etemesil). The study will compare the cumulative rate of gastric ulcers vs. Naprosyn after 12 weeks of treatment.

Read more Medical News

› Verified 4 days ago

Entity NameSamaritan Pacific Health Services Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1174888010
PECOS PAC ID: 2466353529
Enrollment ID: O20040204000304

News Archive

Study: Majority of overweight or obese patients happy with abdominoplasty

Tummy tuck surgery (abdominoplasty) yields high patient satisfaction and improved quality of life in patients who are overweight or obese – despite a substantial risk of complications, reports a study in the October issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons.

Proposed FY13 State, Foreign Operations appropriations bill has 'mixed results' for USAID's global health programs

"On Thursday, the House Appropriations Committee will vote on a State and Foreign Operations (SFOPS) appropriations bill for fiscal year (FY) 2013, which will include funding levels for global health and other programs at the State Department and U.S. Agency for International Development (USAID)," Ashley Bennett, senior policy associate at the Global Health Technologies Coalition (GHTC) writes in the coalition's "Breakthroughs" blog.

Study refutes perinatal programming theory about adipose tissue growth

Is obesity in infants "programmed" in the womb? Previously, researchers assumed that consumption of "bad" fats during pregnancy contribute to excessive infant adipose tissue growth and that "good" omega-3 fatty acids prevent expansive adipose tissue development. A study run by the Technische Universit-t M-nchen showed no evidence to support this "perinatal programming" theory.

Phase 2b clinical study initiated to evaluate GI safety of LT-NS001

Logical Therapeutics, Inc., a Waltham, Mass.-based biotechnology company announced today the initiation of a Phase 2b clinical study to evaluate the gastrointestinal safety of its investigational drug LT-NS001 (naproxen etemesil). The study will compare the cumulative rate of gastric ulcers vs. Naprosyn after 12 weeks of treatment.

Read more Medical News

› Verified 4 days ago

Entity NameSamaritan North Lincoln Hospital
Entity TypePart A Provider - Critical Access Hospital
Entity IdentifiersNPI Number: 1306897491
PECOS PAC ID: 7911816301
Enrollment ID: O20061104000117

News Archive

Study: Majority of overweight or obese patients happy with abdominoplasty

Tummy tuck surgery (abdominoplasty) yields high patient satisfaction and improved quality of life in patients who are overweight or obese – despite a substantial risk of complications, reports a study in the October issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons.

Proposed FY13 State, Foreign Operations appropriations bill has 'mixed results' for USAID's global health programs

"On Thursday, the House Appropriations Committee will vote on a State and Foreign Operations (SFOPS) appropriations bill for fiscal year (FY) 2013, which will include funding levels for global health and other programs at the State Department and U.S. Agency for International Development (USAID)," Ashley Bennett, senior policy associate at the Global Health Technologies Coalition (GHTC) writes in the coalition's "Breakthroughs" blog.

Study refutes perinatal programming theory about adipose tissue growth

Is obesity in infants "programmed" in the womb? Previously, researchers assumed that consumption of "bad" fats during pregnancy contribute to excessive infant adipose tissue growth and that "good" omega-3 fatty acids prevent expansive adipose tissue development. A study run by the Technische Universit-t M-nchen showed no evidence to support this "perinatal programming" theory.

Phase 2b clinical study initiated to evaluate GI safety of LT-NS001

Logical Therapeutics, Inc., a Waltham, Mass.-based biotechnology company announced today the initiation of a Phase 2b clinical study to evaluate the gastrointestinal safety of its investigational drug LT-NS001 (naproxen etemesil). The study will compare the cumulative rate of gastric ulcers vs. Naprosyn after 12 weeks of treatment.

Read more Medical News

› Verified 4 days ago

Entity NameSamaritan Pacific Health Services Inc
Entity TypePart A Provider - Critical Access Hospital
Entity IdentifiersNPI Number: 1801847066
PECOS PAC ID: 2466353529
Enrollment ID: O20061104000163

News Archive

Study: Majority of overweight or obese patients happy with abdominoplasty

Tummy tuck surgery (abdominoplasty) yields high patient satisfaction and improved quality of life in patients who are overweight or obese – despite a substantial risk of complications, reports a study in the October issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons.

Proposed FY13 State, Foreign Operations appropriations bill has 'mixed results' for USAID's global health programs

"On Thursday, the House Appropriations Committee will vote on a State and Foreign Operations (SFOPS) appropriations bill for fiscal year (FY) 2013, which will include funding levels for global health and other programs at the State Department and U.S. Agency for International Development (USAID)," Ashley Bennett, senior policy associate at the Global Health Technologies Coalition (GHTC) writes in the coalition's "Breakthroughs" blog.

Study refutes perinatal programming theory about adipose tissue growth

Is obesity in infants "programmed" in the womb? Previously, researchers assumed that consumption of "bad" fats during pregnancy contribute to excessive infant adipose tissue growth and that "good" omega-3 fatty acids prevent expansive adipose tissue development. A study run by the Technische Universit-t M-nchen showed no evidence to support this "perinatal programming" theory.

Phase 2b clinical study initiated to evaluate GI safety of LT-NS001

Logical Therapeutics, Inc., a Waltham, Mass.-based biotechnology company announced today the initiation of a Phase 2b clinical study to evaluate the gastrointestinal safety of its investigational drug LT-NS001 (naproxen etemesil). The study will compare the cumulative rate of gastric ulcers vs. Naprosyn after 12 weeks of treatment.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Robb Nels Larsen is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Robb Nels Larsen, MD
Po Box 1648,
Eugene, OR 97440-1648

Ph: (541) 242-4812
Dr Robb Nels Larsen, MD
1435 G St,
Springfield, OR 97477-4113

Ph: (541) 242-4812

News Archive

Study: Majority of overweight or obese patients happy with abdominoplasty

Tummy tuck surgery (abdominoplasty) yields high patient satisfaction and improved quality of life in patients who are overweight or obese – despite a substantial risk of complications, reports a study in the October issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons.

Proposed FY13 State, Foreign Operations appropriations bill has 'mixed results' for USAID's global health programs

"On Thursday, the House Appropriations Committee will vote on a State and Foreign Operations (SFOPS) appropriations bill for fiscal year (FY) 2013, which will include funding levels for global health and other programs at the State Department and U.S. Agency for International Development (USAID)," Ashley Bennett, senior policy associate at the Global Health Technologies Coalition (GHTC) writes in the coalition's "Breakthroughs" blog.

Study refutes perinatal programming theory about adipose tissue growth

Is obesity in infants "programmed" in the womb? Previously, researchers assumed that consumption of "bad" fats during pregnancy contribute to excessive infant adipose tissue growth and that "good" omega-3 fatty acids prevent expansive adipose tissue development. A study run by the Technische Universit-t M-nchen showed no evidence to support this "perinatal programming" theory.

Phase 2b clinical study initiated to evaluate GI safety of LT-NS001

Logical Therapeutics, Inc., a Waltham, Mass.-based biotechnology company announced today the initiation of a Phase 2b clinical study to evaluate the gastrointestinal safety of its investigational drug LT-NS001 (naproxen etemesil). The study will compare the cumulative rate of gastric ulcers vs. Naprosyn after 12 weeks of treatment.

Read more News

› Verified 4 days ago


Orthopaedic Surgery Doctors in Springfield, OR

Dr. Thomas J Hasbach, M.D.
Orthopedic Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 3377 Riverbend Dr, Springfield, OR 97477
Phone: 541-222-6245    
Alec Fedorov, M.D.
Orthopedic Surgery
Medicare: Medicare Enrolled
Practice Location: 1435 G St, Springfield, OR 97477
Phone: 541-242-4812    Fax: 541-242-4813

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.